Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmozyme for Chronic Rhinosinusitis in Cystic Fibrosis
NCT00534079Phase 3Completed
- Sponsor
- Friedrich Schiller University Jena
- Start
- Sep 2007
- Primary completion
- Feb 2009
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of dornase alfa in cystic fibrosis (CF), chronic rhinosinusitis (CRS), sponsored by Friedrich Schiller University Jena. Started Sep 2007; status: completed.
02
Drugs
dornase alfa
03
Conditions
cystic fibrosis (CF)chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT00534079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00534079.